The aims of this proof-of-concept study were to describe the effect of age and gender on SSF and its associated metrics, to assess whether patients with post-stroke OD had impaired SSF and to assess the potential therapeutic effect of oropharyngeal sensory stimulation with a TRPV1 agonist such as capsaicin on SSF. The gene discussed is TRPV1; the disease is Stroke.